Management of Irregular Bleeding with DMPA

Treatment Approach

The Centers for Disease Control and Prevention recommends that combination oral contraceptives can be given for heavy or prolonged bleeding associated with DMPA, but only for short-term treatment (10-20 days) during active bleeding episodes 1, 2
Before initiating any treatment, evaluate for pregnancy, sexually transmitted infections, medication interactions, and new uterine pathology, as recommended by the Centers for Disease Control and Prevention 1, 2, 3, 4
For unscheduled spotting or light bleeding, NSAIDs are first-line treatment, according to the Centers for Disease Control and Prevention, and should be used for 5-7 days during active bleeding only 1, 2
For heavy or prolonged bleeding, NSAIDs remain first-line, and combination oral contraceptives or estrogen can be added as second-line if NSAIDs fail, as recommended by the Centers for Disease Control and Prevention 1, 2
Patient must be medically eligible for estrogen-containing contraceptives, with no contraindications such as severe uncontrolled hypertension, migraines with aura, history of thromboembolism or thrombophilia, active liver disease, or complicated valvular heart disease, according to the Centers for Disease Control and Prevention 1, 2, 5

The Centers for Disease Control and Prevention recommends setting realistic expectations, as irregular bleeding with DMPA is common and generally not harmful, and bleeding patterns typically improve with continued DMPA use 3, 5
Enhanced counseling about expected bleeding patterns reduces discontinuation rates, according to the Centers for Disease Control and Prevention 3, 5
If bleeding persists despite treatment and remains unacceptable to the patient, counsel on alternative contraceptive methods, such as long-acting reversible contraceptives (IUD, implant), as recommended by the Centers for Disease Control and Prevention 1, 2, 4, 5